Louis Edward Tamayo
Chief Financial Officer, Lexeo Therapeutics, Inc.
Companies
- Lexeo Therapeutics, Inc.Chief financial officer Aug 27, 2025 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Lexeo Therapeutics, Inc. LXEO92,907 shares2$250.8K at $2.70Aug 18, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 18, 2026Sold 4,117 shares at $4.91 of Lexeo Therapeutics, Inc.2
- Jul 1, 2026Sold 4,641 shares at $4.49 of Lexeo Therapeutics, Inc.3
- Jun 29, 2026Granted 12,000 shares of Lexeo Therapeutics, Inc.3
- Feb 4, 2026Granted 44,665 shares of Lexeo Therapeutics, Inc.4
- Aug 29, 2025Granted 45,000 shares of Lexeo Therapeutics, Inc.5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Jul 1, 2026
- 4SEC EDGARForm 4 filed Feb 6, 2026
- 5SEC EDGARForm 4 filed Sep 3, 2025